Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window

Tero Satomaa, Henna Pynnönen, Olli Aitio, Jukka O. Hiltunen, Virve Pitkänen, Tuula Lähteenmäki, Titta Kotiranta, Annamari Heiskanen, Anna-Liisa Hänninen, Ritva Niemelä, Jari Helin, Heikki Kuusanmäki, Ida Vänttinen, Ramji Rathod, Anni I. Nieminen, Emrah Yatkin, Caroline A. Heckman, Mika Kontro, Juhani Saarinen

Open source

DOI: 10.1158/1535-7163.mct-23-0720
Published: 2024-04-01
Container: Molecular Cancer Therapeutics
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-23-0720,
  title = {Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window},
  author = {Tero Satomaa and Henna Pynnönen and Olli Aitio and Jukka O. Hiltunen and Virve Pitkänen and Tuula Lähteenmäki and Titta Kotiranta and Annamari Heiskanen and Anna-Liisa Hänninen and Ritva Niemelä and Jari Helin and Heikki Kuusanmäki and Ida Vänttinen and Ramji Rathod and Anni I. Nieminen and Emrah Yatkin and Caroline A. Heckman and Mika Kontro and Juhani Saarinen},
  year = {2024},
  journal = {Molecular Cancer Therapeutics},
  doi = {10.1158/1535-7163.mct-23-0720},
  url = {https://doi.org/10.1158/1535-7163.mct-23-0720}
}

RIS

TY  - JOUR
TI  - Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window
AU  - Tero Satomaa
AU  - Henna Pynnönen
AU  - Olli Aitio
AU  - Jukka O. Hiltunen
AU  - Virve Pitkänen
AU  - Tuula Lähteenmäki
AU  - Titta Kotiranta
AU  - Annamari Heiskanen
AU  - Anna-Liisa Hänninen
AU  - Ritva Niemelä
AU  - Jari Helin
AU  - Heikki Kuusanmäki
AU  - Ida Vänttinen
AU  - Ramji Rathod
AU  - Anni I. Nieminen
AU  - Emrah Yatkin
AU  - Caroline A. Heckman
AU  - Mika Kontro
AU  - Juhani Saarinen
PY  - 2024
JO  - Molecular Cancer Therapeutics
DO  - 10.1158/1535-7163.mct-23-0720
UR  - https://doi.org/10.1158/1535-7163.mct-23-0720
ER  -

APA

Satomaa, T., Pynnönen, H., Aitio, O., Hiltunen, J. O., Pitkänen, V., Lähteenmäki, T., Kotiranta, T., Heiskanen, A., Hänninen, A., Niemelä, R., Helin, J., Kuusanmäki, H., Vänttinen, I., Rathod, R., Nieminen, A. I., Yatkin, E., Heckman, C. A., Kontro, M., & Saarinen, J. (2024). Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-23-0720

Source records

crossref · retrieved 2026-09-26T02:17:36.631Z